Cofco Biochemical (China) Performance
| 000930 Stock | 5.92 0.06 1.02% |
On a scale of 0 to 100, Cofco Biochemical holds a performance score of 10. The firm shows a Beta (market volatility) of 0.0669, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Cofco Biochemical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Cofco Biochemical is expected to be smaller as well. Please check Cofco Biochemical's semi deviation, coefficient of variation, and the relationship between the mean deviation and downside deviation , to make a quick decision on whether Cofco Biochemical's price patterns will revert.
Risk-Adjusted Performance
10 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Cofco Biochemical Anhui are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Cofco Biochemical sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor 2:1 | Ex Dividend Date 2023-07-03 | Last Split Date 2005-12-07 |
1 | Lysine Market Advancements Highlighted by Research 2024-2033 Size, Trends, Outlook, Overview - WhaTech | 09/25/2024 |
| Begin Period Cash Flow | 963 M |
Cofco |
Cofco Biochemical Relative Risk vs. Return Landscape
If you would invest 481.00 in Cofco Biochemical Anhui on September 2, 2024 and sell it today you would earn a total of 111.00 from holding Cofco Biochemical Anhui or generate 23.08% return on investment over 90 days. Cofco Biochemical Anhui is generating 0.396% of daily returns and assumes 2.9847% volatility on return distribution over the 90 days horizon. Simply put, 26% of stocks are less volatile than Cofco, and 93% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Cofco Biochemical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cofco Biochemical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Cofco Biochemical Anhui, and traders can use it to determine the average amount a Cofco Biochemical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1327
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 000930 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.98 actual daily | 26 74% of assets are more volatile |
Expected Return
| 0.4 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average Cofco Biochemical is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cofco Biochemical by adding it to a well-diversified portfolio.
Cofco Biochemical Fundamentals Growth
Cofco Stock prices reflect investors' perceptions of the future prospects and financial health of Cofco Biochemical, and Cofco Biochemical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cofco Stock performance.
| Return On Equity | -0.0227 | ||||
| Return On Asset | -0.0062 | ||||
| Profit Margin | (0.01) % | ||||
| Operating Margin | 0.06 % | ||||
| Current Valuation | 13.39 B | ||||
| Shares Outstanding | 1.86 B | ||||
| Price To Book | 1.05 X | ||||
| Price To Sales | 0.53 X | ||||
| Revenue | 20.38 B | ||||
| Gross Profit | 2.08 B | ||||
| EBITDA | 309.22 M | ||||
| Net Income | (601.63 M) | ||||
| Total Debt | 3.22 B | ||||
| Book Value Per Share | 5.65 X | ||||
| Cash Flow From Operations | 1.96 B | ||||
| Earnings Per Share | (0.14) X | ||||
| Total Asset | 16.56 B | ||||
| Retained Earnings | 1.41 B | ||||
About Cofco Biochemical Performance
By analyzing Cofco Biochemical's fundamental ratios, stakeholders can gain valuable insights into Cofco Biochemical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Cofco Biochemical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Cofco Biochemical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Cofco Biochemical is entity of China. It is traded as Stock on SHE exchange.Things to note about Cofco Biochemical Anhui performance evaluation
Checking the ongoing alerts about Cofco Biochemical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cofco Biochemical Anhui help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company reported the revenue of 20.38 B. Net Loss for the year was (601.63 M) with profit before overhead, payroll, taxes, and interest of 2.08 B. | |
| About 58.0% of the company shares are owned by insiders or employees |
- Analyzing Cofco Biochemical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cofco Biochemical's stock is overvalued or undervalued compared to its peers.
- Examining Cofco Biochemical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cofco Biochemical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cofco Biochemical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Cofco Biochemical's stock. These opinions can provide insight into Cofco Biochemical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Cofco Stock analysis
When running Cofco Biochemical's price analysis, check to measure Cofco Biochemical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cofco Biochemical is operating at the current time. Most of Cofco Biochemical's value examination focuses on studying past and present price action to predict the probability of Cofco Biochemical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cofco Biochemical's price. Additionally, you may evaluate how the addition of Cofco Biochemical to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |